Commerzbank AG (0RLW)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 37.69 |
|---|---|
| 52-week range | 26.48 – 43.35 |
| Return, 1 month / 3 months | −10.7% / +0.6% |
| Return, 1 year / 3 years | +27.2% / +300.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 45 |
| Volatility (1 year) | 47.0% |
| Worst drawdown (1 year) | -18.8% |
| Average daily value traded | 60.14M EUR |
| Dividend yield | 2.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Commerzbank is a German bank based in Frankfurt that serves private individuals and businesses. It offers current accounts, savings and lending to retail customers, and provides corporate clients with financing, cash management and trade finance services. Its corporate and investment banking arm supports companies with capital markets and advisory work. The bank operates mainly in Germany, with additional activities across Europe and international financial centres, serving both domestic customers and cross-border corporate clients.
The shares are listed on the London Stock Exchange in UK under the code 0RLW, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Commerzbank AG (0RLW) trades on the London Stock Exchange in UK. It last closed at EUR 37.69 on 27 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 962 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 27.2% and over the last three months it rose 0.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.1% | ||
| From 52-week high | -12.3% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 0.6% | ||
| 6-month return | 12.5% | ||
| 12-month return, skipping the last month | 42.5% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 47.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.8% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 60.14M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 30 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.9% | ||
| Years with dividends | 4 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.3% |
|---|---|
| 1 month | −10.7% |
| 3 months | +0.6% |
| 6 months | +12.5% |
| 1 year | +27.2% |
| 3 years | +300.4% |
| 5 years | +561.0% |
Signals
| 50-day / 200-day average | 39.68 / 35.85 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.95 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 May 2026 | EUR 1.1000 |
| 16 May 2025 | EUR 0.6500 |
| 2 May 2024 | EUR 0.3500 |
| 1 Jun 2023 | EUR 0.2000 |
| 23 May 2019 | EUR 0.2000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.